These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3555505

  • 1. 1,2-Dibromo compounds. Their mutagenicity in Salmonella strains differing in glutathione content and their alkylating potential.
    Zoetemelk CE, Mohn GR, van der Gen A, Breimer DD.
    Biochem Pharmacol; 1987 Jun 01; 36(11):1829-35. PubMed ID: 3555505
    [Abstract] [Full Text] [Related]

  • 2. Mutagenic activity of various chemicals in Salmonella strain TA100 and glutathione-deficient derivatives. On the role of glutathione in the detoxification or activation of mutagens inside bacterial cells.
    Kerklaan PR, Zoetemelk CE, Mohn GR.
    Biochem Pharmacol; 1985 Jun 15; 34(12):2151-6. PubMed ID: 4004932
    [Abstract] [Full Text] [Related]

  • 3. The dependence of the mutagenicity of methanesulphonic acid esters in S. typhimurium TA100 on the alkylation mechanism.
    Eder E, Kütt W.
    Chem Biol Interact; 1989 Jun 15; 69(1):45-59. PubMed ID: 2536596
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Isolation of a mutant of Salmonella typhimurium strain TA1535 with decreased levels of glutathione (GSH-). Primary characterization and chemical mutagenesis studies.
    Kerklaan P, Bouter S, Mohn G.
    Mutat Res; 1983 Dec 15; 122(3-4):257-66. PubMed ID: 6361535
    [Abstract] [Full Text] [Related]

  • 7. Relationships between structures and mutagenic potencies of 16 heterocyclic nitrogen mustards (ICR compounds) in Salmonella typhimurium.
    DeMarini DM, Pham HN, Katz AJ, Brockman HE.
    Mutat Res; 1984 Jun 15; 136(3):185-99. PubMed ID: 6204200
    [Abstract] [Full Text] [Related]

  • 8. Mutagenic properties of allylic and alpha, beta-unsaturated compounds: consideration of alkylating mechanisms.
    Eder E, Henschler D, Neudecker T.
    Xenobiotica; 1982 Dec 15; 12(12):831-48. PubMed ID: 6763406
    [Abstract] [Full Text] [Related]

  • 9. Correlation of alkylating and mutagenic activities of allyl and allylic compounds: standard alkylation test vs. kinetic investigation.
    Eder E, Neudecker T, Lutz D, Henschler D.
    Chem Biol Interact; 1982 Feb 15; 38(3):303-15. PubMed ID: 7037213
    [Abstract] [Full Text] [Related]

  • 10. Mutagenicity of halogenated and other substituted dinitrobenzenes in Salmonella typhimurium TA100 and derivatives deficient in glutathione (TA100/GSH-) and nitroreductase (TA100NR).
    Kerklaan PR, Bouter S, te Koppele JM, Vermeulen NP, van Bladeren PJ, Mohn GR.
    Mutat Res; 1987 Feb 15; 176(2):171-8. PubMed ID: 3543663
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Mutagenic potency of some conjugated nitroaromatic compounds and its relationship to structure.
    Mullin CA, Rashid KA, Mumma RO.
    Mutat Res; 1987 Aug 15; 188(4):267-74. PubMed ID: 3302696
    [Abstract] [Full Text] [Related]

  • 13. Quantitative comparison of carcinogenicity, mutagenicity and electrophilicity of 10 direct-acting alkylating agents and of the initial O6:7-alkylguanine ratio in DNA with carcinogenic potency in rodents.
    Bartsch H, Terracini B, Malaveille C, Tomatis L, Wahrendorf J, Brun G, Dodet B.
    Mutat Res; 1983 Aug 15; 110(2):181-219. PubMed ID: 6348521
    [Abstract] [Full Text] [Related]

  • 14. Quantitative comparisons between carcinogenicity, mutagenicity and electrophilicity of direct-acting N-nitroso compounds and other alkylating agents.
    Bartsch H, Malaveille C, Tomatis L, Brun G, Dodet B, Terracini B.
    IARC Sci Publ; 1982 Aug 15; (41):525-32. PubMed ID: 6754595
    [Abstract] [Full Text] [Related]

  • 15. On the role of alkylating mechanisms, O-alkylation and DNA-repair in genotoxicity and mutagenicity of alkylating methanesulfonates of widely varying structures in bacterial systems.
    Eder E, Kütt W, Deininger C.
    Chem Biol Interact; 2001 Jul 31; 137(1):89-99. PubMed ID: 11518566
    [Abstract] [Full Text] [Related]

  • 16. Mutagenic activation of dibromomethane and diiodomethane by mammalian microsomes and glutathione S-transferases.
    van Bladeren PJ, Breimer DD, Rotteveel-Smijs GM, Mohn GR.
    Mutat Res; 1980 Oct 31; 74(5):341-6. PubMed ID: 7010125
    [Abstract] [Full Text] [Related]

  • 17. A straight correlation between mutagenic activity and beta-galactosidase activity induced by monofunctional alkylating agents.
    Ohtsuka M, Maekawa K.
    Mutat Res; 1992 Sep 31; 283(1):83-6. PubMed ID: 1380669
    [Abstract] [Full Text] [Related]

  • 18. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
    McMahon RE, Cline JC, Thompson CZ.
    Cancer Res; 1979 Mar 31; 39(3):682-93. PubMed ID: 371791
    [Abstract] [Full Text] [Related]

  • 19. Mutagenic activity of cytostatic methyl hydrazones with different strains of Salmonella typhimurium.
    Gericke D, Braun R, Dittmar W.
    Arch Toxicol; 1979 Jul 11; 42(3):179-84. PubMed ID: 383045
    [Abstract] [Full Text] [Related]

  • 20. Hydroxylation and nitroreduction are required to activate dimethylnitramine into alkylating and mutagenic agents.
    Malaveille C, Croisy A, Brun G, Bartsch H.
    Carcinogenesis; 1983 Nov 11; 4(11):1477-81. PubMed ID: 6357524
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.